Daniel McKay

Daniel McKay is an accomplished professional in pharmacovigilance and compliance with extensive experience across several companies in the pharmaceutical industry. Currently serving as Associate Director for GVP Compliance and Global PV Operations at BioMarin Pharmaceutical Inc. since January 2022, Daniel has previously held leadership roles including Quality Director at Panacea and Head of GVP Practice at ADAMAS Consulting. Daniel's expertise encompasses managing global audits, ensuring compliance with Good Vigilance Practices, and overseeing operational activities related to pharmacovigilance at various organizations. With a solid educational background in pharmacovigilance and pharmacology from the University of Hertfordshire and the University of Liverpool, Daniel has consistently contributed to enhancing regulatory affairs and quality assurance processes throughout a diverse career spanning over two decades.